As of December 31, 2025, REMEGEN (09995) announced that it had not yet initiated a share repurchase. The company intends to execute the buyback at an opportune time based on market conditions during the repurchase period and will promptly fulfill its information disclosure obligations in accordance with the progress of the share repurchase activities. This update on the repurchase progress is in full compliance with relevant laws, regulations, and the requirements of the company's repurchase plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments